Cooper Companies, Inc.
COO
Get informed when a big investor buys or sells
+ FollowEarnings Call Q4 2024
December 5, 2024 - AI Summary
Exclusive for Stockcircle Pro members
Sign up
Current Fair Value
16.6% downsideOvervalued by 16.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $12.85 Billion |
|---|---|
| Enterprise Value | $15.30 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.88 |
| Beta | 0.87 |
| Outstanding Shares | 195,000,000 |
Return
| Return on Equity | 2.86% |
|---|---|
| Return on Assets | 1.89% |
| Return on Invested Capital | 4.63% |
Valuation & Multiples
| P/E Ratio | 55.86 |
|---|---|
| PEG | -29.58 |
| Price to Sales | 3.15 |
| Price to Book Ratio | 1.58 |
| Enterprise Value to Revenue | 3.62 |
| Enterprise Value to EBIT | 30.94 |
| Enterprise Value to Net Income | 64 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 0.31 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Next Earnings Call
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.0721▼ 3.82% |
|---|---|
| Total Calls | 120,700▼ 32.42% |
| Total Puts | 129,400▼ 34.75% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 103.81%▲ 1.63% |
|---|---|
| Total Invested | $14.62B▼ 11.89% |
| Investors Holding | 676▲ 1.00% |
ESG Score
No data
About Cooper Companies, Inc.
CEO: Albert White Relevant Senate Committees
This powerful committee controls taxation, trade, and entitlement spending, including Medicare pricing. Changes in tax policy or Medicare reimbursement rates would directly and significantly impact Cooper Companies' profitability and market access.
This committee allocates specific federal spending across various agencies. Its decisions on funding for healthcare programs, scientific research, and federal purchases can directly impact sales and R&D for medical instrument manufacturers.
This committee directly regulates the FDA, which is crucial for medical device approval and oversight. Its decisions on healthcare policy and research funding (NIH) directly impact companies like Cooper Companies.
The Department of Veterans Affairs is a significant purchaser of medical devices. This committee's funding decisions directly impact government healthcare contractors, including medical device manufacturers like Cooper Companies.